Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose aldesleukin in common variable immunodeficiency with autoimmune enteropathy
2015-003369-27Phase 2Completed
- Sponsor
- Universitätsklinikum Freiburg
- Start
- May 2016
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of aldesleukin in common variable immunodeficiency (CVID) and autoimmune enteropathy (AIE), sponsored by Universitätsklinikum Freiburg. Started May 2016; status: completed.
02
Drugs
aldesleukin
03
Conditions
common variable immunodeficiency (CVID)autoimmune enteropathy (AIE)
Beyond the preview
Go deeper on 2015-003369-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003369-27.